China · Delayed Price · Currency is CNY Cabio Biotech (Wuhan) Company Description
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally.
The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (β)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides.
Its products are used in human nutrition, including early life nutrition and dietary supplements; animal nutrition, such as economic animal and pet nutrition; personal care and cosmetics; and synthetic biology applications.
The company also engages in the production of food additives and other food products; consulting services in bioengineering, environmental protection, healthcare, and food technologies; research, development, and sale of biological feed and feed additives; food wholesale; technology development; and venture capital activities.
Cabio Biotech (Wuhan) Co., Ltd. was founded in 1999 and is based in Wuhan, the People’s Republic of China.
| Country | China |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 595 |
| CEO | Dewei Yi |
Contact Details
Address: No. 89, Gaokeyuan Third Road Wuhan, 430075 China | |
| Phone | 86 27 5018 9997 |
| Website | cabio.cn |
Stock Details
| Ticker Symbol | 688089 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005X31 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Dewei Yi | Chairman and GM |
| Huabiao Wang | Financial Director and Director |
| Huarong Yi | Deputy GM and Secretary of the Board of Directors |
| Anfeng Geng | Deputy General Manager |
| Xiangyu Li | Deputy General Manager |
| Hao Xiong | Accounting Supervisor |
| Zhi Bo Li | Deputy General Manager |